Read more
12:14 PM · 1 November 2023

Orsted shares drops more than 18% on big impairment

Orsted
Stocks
ORSTED.DK, Orsted A/S
-
-

Danish company Orsted (ORSTED.DK) has announced that it has taken a 28.4 billion Danish kroner ($4.03 billion) impairment charge for the first nine months of 2023. Moreover, the company will cease work on its US offshore wind projects Ocean Wind 1 and 2.

The provision created due to the discontinuation of Ocean Wind project development will negatively affect EBITDA in Q4 2023. The company's shares are currently losing more than 18%.

Source: xStation

5 November 2025, 3:02 PM

Arista Networks drops 12% despite solid earnings📉Guidance triggered profit-taking on Wall Street

5 November 2025, 2:51 PM

DE40: European stocks under tech pressure

5 November 2025, 11:23 AM

Economic calendar: Key Macroeconomic Data from Europe and the US in Focus for Markets (05.11.2025)

5 November 2025, 10:51 AM

Morning Wrap (05.11.2025)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 2 000 000 investors from around the world